Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL ARYL ETHER SUBSTITUTED HETEROCYCLIC COMPOUND AS GLP1R AGONIST
Document Type and Number:
WIPO Patent Application WO/2023/029380
Kind Code:
A1
Abstract:
The present invention relates to a novel aryl ether substituted heterocyclic compound having GLP1R agonist activity. Specifically, disclosed are a compound as a GLP1R agonist represented by formula (I), or a pharmaceutically acceptable salt, solvate, hydrate, isotope substituent or isomer thereof.

Inventors:
ZHANG LONG (CN)
NIU ZHANGMING (CN)
TANG BOWEN (CN)
Application Number:
PCT/CN2022/075295
Publication Date:
March 09, 2023
Filing Date:
January 31, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MINDRANK AI LTD (CN)
International Classes:
C07D401/14; A61K31/496; A61K31/506; A61P3/00; C07D405/06; C07D405/14; C07D409/14; C07D471/04
Domestic Patent References:
WO2021096284A12021-05-20
WO2020207474A12020-10-15
WO2021112538A12021-06-10
Foreign References:
TW202128658A2021-08-01
US20210171499A12021-06-10
US20200325121A12020-10-15
CN202111017657A2021-08-30
CN202111168512A2021-09-29
Other References:
MEIER ET AL., BIODRUGS, vol. 17, no. 2, 2003, pages 93 - 102
BERGE ET AL.: "Pharmaceutical Salts", JOURNAL OF PHARMACEUTICAL SCIENCE, vol. 66, 1977, pages 1 - 19, XP002675560, DOI: 10.1002/jps.2600660104
MAEHR, J. CHEM. ED, vol. 62, 1985, pages 114 - 120
"Remington: The Science and Practice of Pharmacy", 2005, LIPPINCOTT, WILLIAMS & WILKINS
Attorney, Agent or Firm:
BEIJING ORIGINTELLIGENCE IP LAW FIRM (CN)
Download PDF: